Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
6 "HLA"
Filter
Filter
Article type
Keywords
Publication year
Authors
Funded articles
Brief Report
Diabetes, Obesity and Metabolism
Growth in Children with HLA-Conferred Susceptibility to Type 1 Diabetes
Liisa Saare, Aleksandr Peet, Vallo Tillmann
Endocrinol Metab. 2022;37(1):175-179.   Published online February 28, 2022
DOI: https://doi.org/10.3803/EnM.2021.1262
  • 5,934 View
  • 107 Download
  • 1 Crossref
AbstractAbstract PDFPubReader   ePub   
The incidence of type 1 diabetes (T1D) is increasing throughout the world. This trend may be explained by the accelerator hypothesis. Our study investigated growth, its biochemical markers, and their associations with the development of diabetes-associated autoantibodies (DAAB) in 219 children with genetic risk for T1D. Subjects were divided into risk groups based on their human leukocyte antigen genotype. Children in the moderate- to high-risk group were significantly taller when corrected to mid-parental height and had a lower insulin-like growth factor 1 (IGF-1)/IGF-1 binding protein (IGFBP-3) molar ratio than those in the low-risk group (corrected height standard deviation score 0.22±0.93 vs. –0.04±0.84, P<0.05; molar ratio 0.199±0.035 vs. 0.211+0.039, P<0.05). Children with DAAB tended to be taller and to have a higher body mass index than those with no DAAB. Our results suggest that the accelerator hypothesis explaining the increasing incidence of T1D may not solely be dependent on environmental factors, but could be partially genetically determined.

Citations

Citations to this article as recorded by  
  • Association between disease duration, GH-IGF-1 axis markers, and linear growth in children with type 1 diabetes mellitus: a cross-sectional study
    Feruzakhan Uvaidillaeva, Rustam Tukhvatshin, Valeriia Kniazeva, Baktygul Omurkulova
    Heart, Vessels and Transplantation.2026;[Epub]     CrossRef
Close layer
Case Reports
Thyroid
Celiac Disease in a Predisposed Subject (HLA-DQ2.5) with Coexisting Graves' Disease
In Kyoung Hwang, Seon Hye Kim, Unjoo Lee, Sang Ouk Chin, Sang Youl Rhee, Seungjoon Oh, Jeong-Taek Woo, Sung-Woon Kim, Young Seol Kim, Suk Chon
Endocrinol Metab. 2015;30(1):105-109.   Published online March 27, 2015
DOI: https://doi.org/10.3803/EnM.2015.30.1.105
  • 8,471 View
  • 34 Download
  • 6 Web of Science
  • 6 Crossref
AbstractAbstract PDFPubReader   

Celiac disease is an intestinal autoimmune disorder, triggered by ingestion of a gluten-containing diet in genetically susceptible individuals. The genetic predisposition is related to human leukocyte antigen (HLA) class II genes, especially HLA-DQ2-positive patients. The prevalence of celiac disease has been estimated to be ~1% in Europe and the USA, but it is rarer and/or underdiagnosed in Asia. We report a case of celiac disease in a predisposed patient, with a HLA-DQ2 heterodimer, and Graves' disease that was treated successfully with a gluten-free diet. A 47-year-old woman complained of persistent chronic diarrhea and weight loss over a 9 month period. Results of all serological tests and stool exams were negative. However, the patient was found to carry the HLA DQ2 heterodimer. Symptoms improved after a gluten-free diet was initiated. The patient has been followed and has suffered no recurrence of symptoms while on the gluten-free diet. An overall diagnosis of celiac disease was made in a genetically predisposed patient (HLA-DQ2 heterodimer) with Graves' disease.

Citations

Citations to this article as recorded by  
  • Prevalence of genetic markers of celiac disease in different populations
    G. N. Yankina, E. I. Kondratieva, E. V. Loshkova
    Archives of Pediatrics and Pediatric Surgery.2025; 2(3): 27.     CrossRef
  • Case Series: Is Celiac Disease Underdiagnosed in Korean Children?
    Ji Hyun Moon, Anna Pham-Short, Cheng Hiang Lee, Susan Siew, Nicole Graf, Yoon Hi Cho
    The Korean Journal of Gastroenterology.2025; 85(3): 408.     CrossRef
  • Celiac Disease Genetics, Pathogenesis, and Standard Therapy for Japanese Patients
    Tasuku Tamai, Kenji Ihara
    International Journal of Molecular Sciences.2023; 24(3): 2075.     CrossRef
  • Underutilization of diagnostic assays for celiac disease in Korea
    Rihwa Choi, Sang Gon Lee, Eun Hee Lee
    Journal of Clinical Laboratory Analysis.2021;[Epub]     CrossRef
  • Olmesartan is not associated with the risk of enteropathy: a Korean nationwide observational cohort study
    Seng Chan You, Hojun Park, Dukyong Yoon, Sooyoung Park, Boyoung Joung, Rae Woong Park
    The Korean Journal of Internal Medicine.2019; 34(1): 90.     CrossRef
  • Prevalence of celiac disease in Asia: A systematic review and meta‐analysis
    Prashant Singh, Shubhangi Arora, Alka Singh, Tor A Strand, Govind K Makharia
    Journal of Gastroenterology and Hepatology.2016; 31(6): 1095.     CrossRef
Close layer
Diabetes, Obesity and Metabolism
Recurrent Insulin Autoimmune Syndrome Caused by α-Lipoic Acid in Type 2 Diabetes
Sang Mook Bae, Myoung Nam Bae, Eun Young Kim, Il Kyu Kim, Min Woo Seo, Jin Kyeong Shin, Sung Rae Cho, Gui Hwa Jeong
Endocrinol Metab. 2013;28(4):326-330.   Published online December 12, 2013
DOI: https://doi.org/10.3803/EnM.2013.28.4.326
  • 10,037 View
  • 61 Download
  • 19 Crossref
AbstractAbstract PDFPubReader   

Insulin autoimmune syndrome (IAS) is characterized by spontaneous hypoglycemia caused by insulin autoantibodies in the absence of exogenous insulin administration. Some drugs containing sulfhydryl compounds are known to initiate the onset of IAS. A 67-year-old female who had diabetes for 5 years visited the outpatient clinic at our institution due to diabetic peripheral polyneuropathy. She was prescribed α-lipoic acid (ALA), which contains two sulfur atoms. Two weeks later, she complained of recurrent hypoglycemic symptoms. We detected a high level of insulin and high titers of insulin autoantibodies. Her human leukocyte antigen (HLA) genotype included the DRB1*0406 allele, which indicates a high level of susceptibility to IAS. She was treated with prednisolone. After this episode, she experienced two more hypoglycemic events after taking ALA for diabetic neuropathy in other hospitals. As ALA can be used to treat diabetic peripheral polyneuropathy, physician discretion is advised based on the possibility of IAS due to ALA in diabetic patients.

Citations

Citations to this article as recorded by  
  • HLA Alleles Associate with Insulin Autoimmune Syndrome
    Dan Yao, Jiefeng Jiang, Qianyun Zhou, Caiyun Feng, Jianping Chu, Zhiyan Chen, Jie Yang, Jinying Xia, Yujia Chen
    Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 3463.     CrossRef
  • Hypoglycemia and Multivitamins
    Vaishnavi Revankar, Parth Lakhpatia, Suchitra Kelkar, Sangeeta Chincholkar, Kuldeep Dalal, Kanchan Kewalramani
    Journal of The Association of Physicians of India.2024; 72(8): 99.     CrossRef
  • Long-term follow-up after discharge witnesses a slow decline of insulin autoantibodies in patients with insulin autoimmune syndrome complicated with Grave’s disease: a report of two cases
    Lili Zhao, Jinzhi He, Shandong Ye, Chao Chen, Jie Zhu, Chunchun Xiao, Tingni Wu, Zhicheng Liu
    BMC Endocrine Disorders.2023;[Epub]     CrossRef
  • Postprandial hyperinsulinemic hypoglycemia
    A. A. Akmedova, F. O. Ushanova
    FOCUS. Endocrinology.2023; 4(3): 74.     CrossRef
  • Effects of alpha lipoic acid on metabolic syndrome: A comprehensive review
    Nahid Najafi, Soghra Mehri, Mahboobeh Ghasemzadeh Rahbardar, Hossein Hosseinzadeh
    Phytotherapy Research.2022; 36(6): 2300.     CrossRef
  • Alpha-Lipoic Acid and Glucose Metabolism: A Comprehensive Update on Biochemical and Therapeutic Features
    Umberto Capece, Simona Moffa, Ilaria Improta, Gianfranco Di Giuseppe, Enrico Celestino Nista, Chiara M. A. Cefalo, Francesca Cinti, Alfredo Pontecorvi, Antonio Gasbarrini, Andrea Giaccari, Teresa Mezza
    Nutrients.2022; 15(1): 18.     CrossRef
  • Analysis of the clinical characteristics of insulin autoimmune syndrome induced by alpha‐lipoic acid
    Zuojun Li, Yanhong Su, Dan Yi, Cuifang Wu, Weijin Fang, Chunjiang Wang
    Journal of Clinical Pharmacy and Therapeutics.2021; 46(5): 1295.     CrossRef
  • Scientific opinion on the relationship between intake of alpha‐lipoic acid (thioctic acid) and the risk of insulin autoimmune syndrome
    Dominique Turck, Jacqueline Castenmiller, Stefaan de Henauw, Karen Ildico Hirsch‐Ernst, John Kearney, Helle Katrine Knutsen, Inge Mangelsdorf, Harry J McArdle, Androniki Naska, Carmen Pelaez, Kristina Pentieva, Alfonso Siani, Frank Thies, Sophia Tsabouri,
    EFSA Journal.2021;[Epub]     CrossRef
  • Management of Insulin Autoimmune Hypoglycaemia: Single‐centre experience from Western India with systematic review of world literature
    Muniraj Patel, Ravikumar Shah, Swati Ramteke‐Jadhav, Virendra Patil, Shivendra Kumar Patel, Anurag Lila, Nalini Shah, Tushar Bandgar
    Clinical Endocrinology.2020; 92(5): 409.     CrossRef
  • Glucose Changes in a Patient With Insulin Autoimmune Syndrome Demonstrated by Continuous Glucose Monitoring
    Shi-Dou Lin, Shang-Ren Hsu
    AACE Clinical Case Reports.2019; 5(1): e35.     CrossRef
  • Insulin Autoimmune Syndrome in a 25-Year-Old, Previously Healthy Kuwaiti Man
    Einas Alrashidi, Thamer Alessa
    Case Reports in Endocrinology.2019; 2019: 1.     CrossRef
  • Insulin autoimmune syndrome in an Argentine woman taking α-lipoic acid: A case report and review of the literature
    Valentina Izzo, Carla Greco, Diana Corradini, Marco Infante, Maria Teresa Staltari, Maria Romano, Alfonso Bellia, Davide Lauro, Luigi Uccioli
    SAGE Open Medical Case Reports.2018;[Epub]     CrossRef
  • Assessment and Management of Anti-Insulin Autoantibodies in Varying Presentations of Insulin Autoimmune Syndrome
    David Church, Luís Cardoso, Richard G Kay, Claire L Williams, Bernard Freudenthal, Catriona Clarke, Julie Harris, Myuri Moorthy, Efthmia Karra, Fiona M Gribble, Frank Reimann, Keith Burling, Alistair J K Williams, Alia Munir, T Hugh Jones, Dagmar Führer,
    The Journal of Clinical Endocrinology & Metabolism.2018; 103(10): 3845.     CrossRef
  • Current Status of Health Foods Including Their Interactions with Drugs and Adverse Events
    Yoshiro Saito
    YAKUGAKU ZASSHI.2018; 138(12): 1511.     CrossRef
  • Autoimmune hypoglycaemia caused by alpha-lipoic acid: a rare condition in Caucasian patients
    A Veltroni, G Zambon, S Cingarlini, M V Davì
    Endocrinology, Diabetes & Metabolism Case Reports.2018;[Epub]     CrossRef
  • GLP‑1R agonists ameliorate peripheral nerve dysfunction and inflammation via p38 MAPK/NF‑κB signaling pathways in streptozotocin‑induced diabetic rats
    Jingjing Ma, Min Shi, Xiangcheng Zhang, Xiaoning Liu, Juan Chen, Ridong Zhang, Xingzhou Wang, Hong Zhang
    International Journal of Molecular Medicine.2018;[Epub]     CrossRef
  • Insulin autoimmune syndrome associated with alpha-lipoic acid in a young woman with no concomitant disease
    Sang Bae Lee, Min Young Lee, Ji Hong You, Seong Han Kim, Ji Sun Nam
    Yeungnam University Journal of Medicine.2017; 34(1): 115.     CrossRef
  • The insulin autoimmune syndrome (IAS) as a cause of hypoglycaemia: an update on the pathophysiology, biochemical investigations and diagnosis
    Adel A.A. Ismail
    Clinical Chemistry and Laboratory Medicine (CCLM).2016; 54(11): 1715.     CrossRef
  • Brief Review of Articles in 'Endocrinology and Metabolism' in 2013
    Won-Young Lee
    Endocrinology and Metabolism.2014; 29(3): 251.     CrossRef
Close layer
A Case of Fulminant Type 1 Diabetes Mellitus with Human Leukocyte Antigen DR4-DQ4.
Ye Ri So, Ja Won Koo, Young Hak Cho, You Cheol Hwang, Kyu Jeung Ahn, Ho Yeon Chung, In Kyung Jeong
Endocrinol Metab. 2012;27(4):314-317.   Published online December 20, 2012
DOI: https://doi.org/10.3803/EnM.2012.27.4.314
  • 2,694 View
  • 21 Download
AbstractAbstract PDF
The clinical characteristics of fulminant type 1 diabetes are abrupt onset of disease, very short (<1 week) duration of diabetic symptoms, ketoacidosis at diagnosis, negativity for islet-related autoantibodies, virtually no C-peptide secretion (fasting plasma C-peptide <0.3 ng/mL), a near normal hemoglobin A1c (HbA1c) level and an elevated serum pancreatic enzyme level. The pathogenesis has not yet been clarified, however the involvement of both genetic background and viral infections has been suggested. We reported a case of fulminant type 1 diabetes. A 37-year-old woman was admitted with stuporous consciousness to our hospital. Four days prior to the admission, she was hospitalized with the diagnosis of acute pancreatitis in another hospital, and at that time her glucose level was 79 mg/dL. Three days after the hospitalization, her state of consciousness became stuporous and she was transferred to our hospital. The laboratory results were as follows: pH 6.94, glucose 1,602 mg/dL, and HbA1c 5.5%. She was negative for islet-related autoantibodies and viral antibodies. HLA haplotypes were DRB1*04:05/*04:06, DQB1*03:02/*04:01 which might be a considerable risk allele for fulminant type 1 diabetes. She was diagnosed with fulminant type 1 diabetes, and has been treated with multiple component insulin regimens.
Close layer
Original Articles
HLA, CTLA-4 and TNF-beta Gene Polymorphisms and Disease Susceptibility in Korean Children with Graves' Disease.
Moon Young Song, Min Ho Jung, Jun Seong Lee, Tai Gyu Kim, Sei Won Yang, Byung Churl Lee
J Korean Endocr Soc. 2003;18(1):32-44.   Published online February 1, 2003
  • 1,716 View
  • 20 Download
AbstractAbstract PDF
BACKGROUND
Graves' disease(GD) is an organ-specific autoimmune disorder that is inherited as a complex trait. At present three loci, namely the human leukocyte antigen(HLA), the cytotoxic T lymphocyte antigen-4(CTLA-4) and a thyroid stimulating hormone receptor(TSHR) are the only well-known genetic determinants for GD. To understand the mechanisms underlying the development of GD, we investigated the relationship of HLA alleles, polymorphisms of CTLA-4 gene and the tumor necrosis factor(TNF)-beta gene, with the disease susceptibility. METHODS: Fifty-two Korean children with GD(45 girls and 7 boys), and 119 healthy children, were investigated in this study. The HLA alleles were determined by a standard lymphocyte microtoxicity technique, ARMS-PCR(Amplification Refractory Mutation System-Polymerase Chain Reaction), PCR-SSP(Sequence Specific Primer) and PCR-SSOP(Sequence Specific Oliogonucleotide Probe) method. The CTLA-4 gene polymorphism was analyzed by PCR-SSCP(Single Strand Conformation Polymorphism), and the TNF-beta gene polymorphism by PCR-RFLP(Restriction Fragment Length Polymorphism). RESULTS: (1) The frequencies of HLA-A2, B46, DRB1*08 and DPB1*0202 were significantly increased, and those of HLA-A24, DQA1*01 and DQB1*05 were significantly decreased, in the GD patients compared to the control subjects. (2) A significant difference in the distributions of the AA, AG, and GG genotypes of the CTLA-4 exon 1 were observed between the GD patients and the control subjects, and a significant increase in the frequency of the G (alanine) allele was seen in the GD patients compared with the control subjects(84.6% vs 63.4%; RR=3.2; p<0.0001). A significant difference in the distributions of the AA, AG, and GG genotypes of the CTLA-4 exon 1 was observed between the GD patients with and without exophthalmos. A significant increase in the frequency of the G allele was seen in the GD patients with exophthalmos compared to those without(94.0% vs 75.9%; RR=7.0; p<0.05). (3) No significant difference in the distributions of the 1/1, 1/2 and 2/2 genotypes, and the 1 and 2 alleles of TNF-beta was observed between the GD patients and the control subjects. No significant difference in the distributions of the 1/1, 1/2, and 2/2 genotypes and the 1 and 2 alleles of TNF-beta were observed between the GD patients with or without exophthalmos but a significant increase in the frequency of the 2/2 allele was seen in the GD patients having TSHRAb > or =45% compared with GD patients having TSHRAb <45%(37.5% vs 3.6%; RR=14.8; p<0.01). CONCLUSION: These data suggest that HLA-A2, B46, Cw*0102, DRB1*08 and DPB1*0202 are markers for disease susceptibility, and that HLA-A24, DQA1*01 and DQB1*05 are markers for disease protection, in Korean children with GD. This study showed that the CTLA-4 gene polymorphism was an additional marker of susceptibility in the GD patients, and was associated with exophthalmos, and that the TNF-beta gene polymorphism was associated with the TSHRAb activity.
Close layer
Three Cases of Autoimmune Thyroid Disease in a Family through Three Generation.
Byoung youp Kim, Min young Lee, In Gyun Oh, DO Hyoung Kim, Hak Chan Kim, Sang Eok Kim, Seung Hae Han, Dong Hoon Shin, Eun Sil Kim, Chong Soon Kim
J Korean Endocr Soc. 2001;16(2):238-244.   Published online April 1, 2001
  • 1,775 View
  • 18 Download
AbstractAbstract PDF
According to recent studies, the immunogenetic factors are thought to be account for a part of the etiopathogenesis of autoimmune thyroid disease. In Korea, there was one report on the relationship between HLA DR5, DR8, B13 and autoimmune thyroid disease. There were also several reports on a familial hereditary transmission of autoimmune thyroid disease in other countries but not in Korea. We describe the occurrence of autoimmune thyroid disease that affected three members of a family through three generations. This is the first report on familial hereditary transmission of autoimmune thyroid disease in Korea. We report on an 80-year-old woman who presented with Hashimoto's thyroiditis, her 53-year-old daughter who had Graves' disease, and her 29-year-old grand-daughter who had Graves' disease. In order to identify the immunogenetic influence in these cases, HLA haplotypes & thyroid autoantibody were studied. HLA DRB3*02 was obseved in each of the patents. HLA DQB1*0301, DR11, DQB1*05031 and DR14 were observed in the two cases. However, HLA B13, DR5 and DR8 were not observed. The patients are currently undergoing follow-up using PTU, methimazole and synthyroid medication.
Close layer

Endocrinol Metab : Endocrinology and Metabolism
TOP